Phreesia, Inc. $PHR Shares Purchased by Arcadia Investment Management Corp MI

Arcadia Investment Management Corp MI boosted its holdings in Phreesia, Inc. (NYSE:PHR) by 22.3% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 113,470 shares of the company’s stock after buying an additional 20,700 shares during the quarter. Arcadia Investment Management Corp MI owned approximately 0.19% of Phreesia worth $3,229,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of PHR. Farther Finance Advisors LLC boosted its holdings in Phreesia by 9,375.0% in the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock valued at $86,000 after purchasing an additional 3,000 shares in the last quarter. CWM LLC boosted its holdings in shares of Phreesia by 994.9% in the 1st quarter. CWM LLC now owns 4,040 shares of the company’s stock valued at $103,000 after buying an additional 3,671 shares in the last quarter. Smartleaf Asset Management LLC grew its position in shares of Phreesia by 53.0% in the 1st quarter. Smartleaf Asset Management LLC now owns 5,267 shares of the company’s stock valued at $137,000 after buying an additional 1,825 shares during the last quarter. Entropy Technologies LP purchased a new position in shares of Phreesia in the 1st quarter valued at $202,000. Finally, Teacher Retirement System of Texas acquired a new stake in Phreesia during the 1st quarter worth $206,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Stock Performance

NYSE:PHR opened at $21.77 on Friday. The firm’s fifty day simple moving average is $23.36 and its 200-day simple moving average is $25.82. The company has a quick ratio of 2.12, a current ratio of 2.12 and a debt-to-equity ratio of 0.02. The stock has a market cap of $1.30 billion, a PE ratio of -51.84 and a beta of 0.74. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $32.76.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Thursday, September 4th. The company reported $0.01 EPS for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.08. Phreesia had a negative net margin of 5.35% and a negative return on equity of 8.75%. The firm had revenue of $117.26 million for the quarter, compared to the consensus estimate of $116.39 million. During the same quarter in the previous year, the firm earned ($0.03) earnings per share. The firm’s revenue was up 14.9% on a year-over-year basis. Phreesia has set its FY 2026 guidance at EPS. Analysts expect that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Insider Transactions at Phreesia

In related news, insider Evan Roberts sold 45,147 shares of Phreesia stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $32.02, for a total transaction of $1,445,606.94. Following the completion of the transaction, the insider directly owned 727,768 shares of the company’s stock, valued at approximately $23,303,131.36. The trade was a 5.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, General Counsel Allison C. Hoffman sold 3,133 shares of the company’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $23.28, for a total value of $72,936.24. Following the completion of the sale, the general counsel directly owned 139,037 shares in the company, valued at $3,236,781.36. This trade represents a 2.20% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 92,244 shares of company stock valued at $2,680,720. Company insiders own 5.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on PHR. JMP Securities upped their price objective on shares of Phreesia from $30.00 to $34.00 and gave the company a “market outperform” rating in a research note on Monday, September 8th. Needham & Company LLC boosted their target price on Phreesia from $29.00 to $35.00 and gave the company a “buy” rating in a report on Friday, September 5th. Weiss Ratings restated a “sell (e+)” rating on shares of Phreesia in a research note on Friday, October 31st. Raymond James Financial set a $33.00 price target on Phreesia and gave the stock an “outperform” rating in a research report on Friday, September 5th. Finally, Piper Sandler upped their price target on shares of Phreesia from $33.00 to $34.00 and gave the company an “overweight” rating in a research report on Friday, September 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $33.71.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.